Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats

European Journal of Pharmacology

Volumn 606, Issue 1-3, 2009, Pages 137-141

  Qu, You Zhi ^a   Li, Min ^a   Zhao, Yan Ling ^b   Zhao, Zhen Wei ^a   Wei, Xiao Yan ^c   Liu, Jin Ping ^c   Gao, Li ^a   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Astragaloside IV; Blood brain barrier; Cerebral ischemia and reperfusion; Occludin; Tight junction; ZO 1

Indexed keywords

ASTRAGALOSIDE IV; ASTRAGALUS MEMBRANACEUS EXTRACT; EVANS BLUE; LANTHANUM; OCCLUDIN; PROTEIN ZO1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALUS MEMBRANACEUS; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN CAPILLARY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON; PERMEABILITY; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SAPONINS; TIGHT JUNCTIONS; TRITERPENES;

EID: 60949092865     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.01.022     Document Type: Article

References (24)

1. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
2. Bradbury M.W., and Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology 14 (1993) 131-136
3. Cai Y.H., Qin Z., and Yao Q.L. A prospective, pilot study of astragalus membranaceus in the treatment of acute cerebral infarction. J. Clin. Neurol. 7 (1994) 216-218
4. Casella G.T., Marcillo A., Bunge M.B., and Wood P.M. New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp. Neurol. 173 (2002) 63-76
5. Chang Y., Hsiao G., Chen S.H., Chen Y.C., Lin J.H., Lin K.H., Chou D.S., and Sheu J.R. Tetramethylpyrazine suppresses HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats. Acta Pharmacol. Sin. 28 (2007) 327-333
6. Chi O.Z., Hunter C., Liu X., and Weiss H.R. Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia. Pharmacology 82 (2008) 38-42
7. Czarnowska E., and Karwatowska-Prokopczuk E. Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Res. Cardiol. 90 (1995) 357-364
8. Date I., Takagi N., Takagi K., Tanonaka K., Funakoshi H., Matsumoto K., Nakamura T., and Takeo S. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels. Neurosci. Lett. 407 (2006) 141-145
9. Gao M., Liu R., Zhu S.Y., and Du G.H. Acute neurovascular unit protective action of pinocembrin against permanent cerebral ischemia in rats. J. Asian Nat. Prod. Res. 10 (2008) 551-558
10. Hom S., Fleegal M.A., Egleton R.D., Campos C.R., Hawkins B.T., and Davis T.P. Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 292 (2007) 1881-1892
11. Huang J., Upadhyay U.M., and Tamargo R.J. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 66 (2006) 232-245
12. Kago T., Takagi N., Date I., Takenaga Y., Takagi K., and Takeo S. Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem. Biophys. Res. Commun. 339 (2006) 1197-1203
13. Li Y., Lu Z.Y., Ogle M., and Wei L. Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice. Neurochem. Res. 32 (2007) 2132-2141
14. Li Z.P., and Cao Q. Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol. Sin. 23 (2002) 898-904
15. Luo Y., Qin Z., Hong Z., Zhang X., Ding D., Fu J.H., Zhang W.D., and Chen J. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci. Lett. 363 (2004) 218-223
16. Lu S., Zhang J., and Yang D. Effects of astragaloside IV in treating myocardial injury and myocardial sarco/endoplasmic Ca (2+)-ATP ase of viral myocarditis mice, Chin. J. Integr. Med. 19 (1999) 672-674
17. Matter K., and Balda M.S. Functional analysis of tight junctions. Methods 30 (2003) 228-234
18. Sundstrom R., Muntzing K., Kalimo H., and Sourander P. Changes in the integrity of the blood-brain barrier in suckling rats with low dose lead encephalopathy. Acta Neuropathol. 68 (1985) 1-9
19. Wang Q., Luo W., Zheng W., Liu Y., Xu H., Zheng G., Dai Z., Zhang W., Chen Y., and Chen J. Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. Toxicol. Appl. Pharmacol. 219 (2007) 33-41
20. Wang Y.P., Li X.Y., Song C.Q., and Hu Z.B. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol. Sin. 23 (2002) 263-266
21. Yang Q., Lu J.T., Zhou A.W., Wang B., He G.W., and Chen M.Z. Antinociceptive effect of astragalosides and its mechanism of action. Acta Pharmacol. Sin. 22 (2001) 809-812
22. Zhang L.F., Yang J., Hong Z., Yuan G.G., Zhou B.F., Zhao L.C., Huang Y.N., Chen J., and Wu Y.F. Proportion of different subtypes of stroke in China. Stroke 34 (2003) 2091-2096
23. Zhang W.J., Hufnagl P., Binder B.R., and Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb. Haemost. 90 (2003) 904-914
24. Zhang W.D., Zhang C., Liu R.H., Li H.L., Zhang J.T., Mao C., Moran S., and Chen C.L. Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs. Life Sci. 79 (2006) 808-815